Anna Frostegård has completed her Phd in Copenhagen University at Denmark in 2014. She is an Aspirant at Stage 1 specialization in the Medicines. She is currently working in Annexin Pharmaceuticals as Chief Scientific och Medical Officer, which is situated at Sweden.
Research Intrest
She is intersted in R and D in reproductive Medicines.